GLR Partners, LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 2134831 COLUMBIA, MD

Position in REGN

as of Jun 30, 2026 · filed Jul 27, 2026 Compact

Position Value

$218,239

-$52,185 QoQ

Shares Held

350

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.23%

of 13F equity value

Holder Rank

#311

of 454 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

GLR Partners, LLC holds $1,837,830 across 3 Biotechnology names. REGN ranks #3 (11.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BRNS	Barinthus Biotherapeutics plc.	1,243,377	$820,628
2	PGEN	Precigen, Inc.	140,169	$798,963
3	REGN	Regeneron Pharmaceuticals, Inc. This page	350	$218,239

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$218,239	350	0.0%	Shares	Sole	2026-07-27
2026-03-31	$270,424	350	—	Shares	Sole	2026-05-13
No filing history on record for this holder in this stock.